Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

Hemasphere. 2022 Oct 12;6(11):e787. doi: 10.1097/HS9.0000000000000787. eCollection 2022 Nov.

Martin Kirschner^{1

2}, Benjamin Rolles^{1

2}, Martina Crysandt^{1

2}, Christoph Röllig³, Friedrich Stölzel³, Michael Kramer³, Martin Bornhäuser³, Hubert Serve⁴, Uwe Platzbecker⁵, Carsten Müller-Tidow⁶, Kim Kricheldorf^{1

2}, Margherita Vieri^{1

2}, Matthias Begemann⁷, Angela Maurer^{1

2}, Marcin W Wlodarski^{8

9}, Sushree S Sahoo⁹, Tim H Brümmendorf^{1

2}, Edgar Jost^{1

2}, Fabian Beier^{1

2}

¹ Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Germany.
² Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Germany.
³ Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Germany.
⁴ Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
⁵ Department of Medicine I, Hematology, Cellular Therapy, Hemostaseology, University of Leipzig, Germany.
⁶ Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Germany.
⁷ Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Germany.
⁸ Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center, University of Freiburg, Germany.
⁹ Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.

No abstract available